These 5 consumer stocks are the ones to keep an eye on now.
Read MoreBuy Target $1.22 Sell Target $1.41 Trailing Stop 20% BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for […]
Read MoreWall Street sees double-digit upside ahead for these 6 stocks. Here’s why.
Read MoreAs the earnings season heats up, Morgan Stanley is betting on these 4 stocks.
Read MoreNo. 5: Union Pacific Corp. (UNP) Shares of Union Pacific — which operates the largest railroad system in the U.S. and is one of the world’s largest transportation companies in general — surged 5.9% during Thursday’s session from the previous close of $164.55 to $174.25. With that settlement, UNP stock is now up more than […]
Read MoreTrade Setup Buy Target $3.49 Sell Target $4.16 Trailing Stop 20% Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a […]
Read MoreOne of the most underwhelming sectors in this market this year has been Healthcare. As measured by the S&P 500 Healthcare Sector SPDR ETF (XLV), the sector is up just about 6.5% year to date, while the broad market hit a new all-time high earlier and is up a little over 19% since the beginning […]
Read More